Literature DB >> 16339403

Lack of F8 mRNA: a novel mechanism leading to hemophilia A.

Osman El-Maarri1, Heike Singer, Claudia Klein, Matthias Watzka, Ursula Herbiniaux, Hans H Brackmann, Jörg Schröder, Jochen Graw, Clemens R Müller, Wolfgang Schramm, Rainer Schwaab, Thomas Haaf, Peter Hanfland, Johannes Oldenburg.   

Abstract

Hemophilia A (HA) is caused by partial or total deficiency of F8 protein activity. In a small group, about 1.8% of patients with HA, no mutation is found in the F8 gene. Among this group, we report here on one patient with severe HA in whom no mRNA of the F8 gene was detected. Using 2 common polymorphisms in F8 exon 14, we were able to show that the same allele shared by the patient, his mother, and his sister was not detected by reverse transcription-polymerase chain reaction (RT-PCR) from total blood mRNA. Skewed X-chromosome inactivation in both the mother and the sister was excluded by studying the methylation profile of the androgen receptor gene (HUMARA locus). These findings strongly suggest that the cause of HA in this patient is either absence or rapid degradation of the F8 mRNA, which points to a novel mechanism leading to HA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339403     DOI: 10.1182/blood-2005-09-3702

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

Review 1.  New insight into the molecular basis of hemophilia A.

Authors:  Johannes Oldenburg; Osman El-Maarri
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

2.  Mutations in intron 1 and intron 22 inversion negative haemophilia A patients from Western India.

Authors:  Preethi S Nair; Shrimati D Shetty; S Chandrakala; Kanjaksha Ghosh
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

3.  Mutation analysis in the F8 gene in 485 families with haemophilia A and prenatal diagnosis in China.

Authors:  Yin Feng; Qianqian Li; Panlai Shi; Ning Liu; Xiangdong Kong; Ruixia Guo
Journal:  Haemophilia       Date:  2020-11-27       Impact factor: 4.287

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.